Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Aevi Genomic Medicine Inc. (GNMX)

0.1234   -0.008 (-5.8%) 11-12 15:59
Open: 0.133 Pre. Close: 0.131
High: 0.135 Low: 0.12
Volume: 1,013,970 Market Cap: 8M
Aevi Genomic Medicine Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.14 - 0.141 0.141 - 0.142
Low: 0.118 - 0.119 0.119 - 0.12
Close: 0.119 - 0.12 0.12 - 0.121

Technical analysis

as of: 2019-11-12 4:28:14 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.16     One year: 0.18
Support: Support1: 0.11    Support2: 0.09
Resistance: Resistance1: 0.13    Resistance2: 0.15
Pivot: 0.13
Moving Average: MA(5): 0.13     MA(20): 0.13
MA(100): 0.17     MA(250): 0.30
MACD: MACD(12,26): -0.01     Signal(9): -0.01
Stochastic oscillator: %K(14,3): 26.00     %D(3): 30.89
RSI: RSI(14): 39.30
52-week: High: 1.30  Low: 0.11  Change(%): -89.5
Average Vol(K): 3-Month: 49081  10-Days: 49873

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GNMX has closed above bottom band by 11.6%. Bollinger Bands are 66.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to GNMX's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 16 Jul 2019 19:51:00 +0000
Health Care Sector Update for 07/16/2019: ONCS,CGIX,IDXG,GNMX,JNJ

Tue, 16 Jul 2019 18:10:46 +0000
Health Care Sector Update for 07/16/2019: CGIX,IDXG,GNMX,JNJ

Mon, 12 Mar 2018 08:00:03 +0000
Pre-Market Earnings Report for March 13, 2018 : HDS, DKS, GDS, DSW, EPZM, NRE, ATRS, MLNT, ARLZ, GNMX, TSQ, GLMD

Thu, 27 Apr 2017 14:40:35 +0000
Thursday 4/27 Insider Buying Report: MAT, GNMX

Fri, 21 Apr 2017 05:34:37 +0000
Friday Sector Laggards: Drugs, Biotechnology Stocks

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 64.77
Shares Float (M) 54.95
% Held by Insiders 42.43
% Held by Institutions 19.10
Shares Short (K) 642
Shares Short P. Month (K)

Stock Financials

EPS -0.349
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -115.8
Return on Equity (ttm) -286.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.346
Qtrly Earnings Growth
Operating Cash Flow (M) -20.84
Levered Free Cash Flow (M) -12.53

Stock Valuations

P/E -0.35
P/E Growth Ratio -0.05
P/CF -0.38

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.